Wealth Watch Advisors’s Merck MRK Stock Holding History

Wealth Watch Advisors’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,728	Closed	-$208K	–	147
2026 Q1	$208K	Buy	1,728 +1,336	+341%	+$154K	0.09%	104
2025 Q4	$41.3K	Sell	392 -18	-4%	-$1.69K	0.02%	232
2025 Q3	$34.4K	Buy	+410	New	+$33.8K	0.01%	239

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wealth Watch Advisors's MRK Position: Q2 2026 in Review

Wealth Watch Advisors sold out of Merck (MRK) in Q2 2026, closing a stake of 1,728 shares — an estimated $208K sold.

Wealth Watch Advisors first reported a position in MRK in Q3 2025 and held it in 3 quarters. The position peaked at $208K in Q1 2026. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Wealth Watch Advisors reported no remaining Merck position as of Q2 2026 after selling out during the quarter.
Wealth Watch Advisors sold 1,728 Merck shares in Q2 2026, an estimated $208K.
Wealth Watch Advisors first reported a position in Merck in Q3 2025 and held it in 3 quarters.
Wealth Watch Advisors's Merck position peaked at $208K in Q1 2026.
3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Wealth Watch Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.